Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q2 EPS of ($0.01), $0.06 worse than the analyst estimate of $0.05. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE